Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Kash Sheikh | EVE EVe Mobility Acquisition Corp | 13D/A | 59.7% | Feb 2, 2024 | 2y |
| Cano Health, Inc. | MSPR MSP Recovery, Inc. | 13D/A | 37.5% | Feb 2, 2024 | 2y |
| Global Graphene Group, Inc. | STI Solidion Technology Inc. | 13D | 90.4% | Feb 2, 2024 | 2y |
| Redmile Group, LLC | MDVL MedAvail Holdings, Inc. Common Stock | 13D/A | 73% | Feb 2, 2024 | 2y |
| Conversant GP Holdings LLC | SNDA Sonida Senior Living, Inc. | 13D/A | 62% | Feb 1, 2024 | 2y |
| Lind Global Fund II LP | SIDU Sidus Space Inc. | 13G | 8.3% | Feb 1, 2024 | 2y |
| Harraden Circle Investments, LLC | BLUA BlueRiver Acquisition Corp. | 13G | 5.61% | Feb 1, 2024 | 2y |
| WELLINGTON MANAGEMENT GROUP LLP | IMCR Immunocore Holdings plc | 13G/A | 11.12% | Jan 31, 2024 | 2y |
| GILDER GAGNON HOWE & CO LLC | SDHC Smith Douglas Homes Corp. | 13G | 11.7% | Jan 31, 2024 | 2y |
| WELLINGTON MANAGEMENT GROUP LLP | GPCR Structure Therapeutics Inc. | 13G/A | 11.41% | Jan 31, 2024 | 2y |
| L.I.A. Pure Capital Ltd. | RVSN Rail Vision Ltd. | 13G/A | 4.66% | Jan 31, 2024 | 2y |
| Harraden Circle Investments, LLC | CHAA Catcha Investment Corp | 13G | 7.22% | Jan 29, 2024 | 2y |
| ZUU Co. Ltd. | SBC SBC Medical Group Holdings Inc | 13D | 24.4% | Jan 26, 2024 | 2y |
| Phillip Frost, M.D. | BCDA BioCardia, Inc. | 13D/A | 8.8% | Jan 19, 2024 | 2y |
| Phillip Frost, M.D. | VERU Veru Inc. | 13G/A | 3.5% | Jan 16, 2024 | 2y |
| Octagon Capital Advisors LP | XLO Xilio Therapeutics, Inc. | 13G/A | 0% | Jan 2, 2024 | 2y |
| Mitchell P. Kopin | HSDT Solana Co | 13G/A | 0.1% | Dec 31, 2023 | 2y |
| Menachem Wilenkin | FINW Finwise Bancorp | 13G/A | 6.62% | Dec 31, 2023 | 2y |
| NORDEA INVESTMENT MANAGEMENT AB | MTZ Mastec Inc | 13G | 5% | Dec 31, 2023 | 2y |
| Cetus Capital VI, L.P. | CBL Cbl & Associates Properties Inc | 13G/A | 3.26% | Dec 31, 2023 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 14.7% | Dec 31, 2023 | 2y |
| Mitchell P. Kopin | BXRX Baudax Bio, Inc. Common Stock | 13G/A | 1.8% | Dec 31, 2023 | 2y |
| VLADIMIR SHMUNIS | RNG RingCentral, Inc. | 13G/A | 5.3% | Dec 31, 2023 | 2y |
| Chen Xiangdong | GOTU Gaotu Techedu Inc. | 13G/A | 45.8% | Dec 31, 2023 | 2y |
| WELLS FARGO & COMPANY/MN | SIEN Sientra, Inc. | 13G | 8.8% | Dec 31, 2023 | 2y |
| BlackRock Inc. | BKF iShares, Inc. | 13G/A | 5% | Dec 31, 2023 | 2y |
| Anders Hove | BCAB BioAtla, Inc. | 13G/A | 8.4% | Dec 31, 2023 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 10.5% | Dec 31, 2023 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 59.4% | Dec 31, 2023 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G | 6.5% | Dec 31, 2023 | 2y |
| SIT INVESTMENT ASSOCIATES INC | DBL DoubleLine Opportunistic Credit Fund | 13G/A | 17.04% | Dec 31, 2023 | 2y |
| GENEVA CAPITAL MANAGEMENT LLC | ROAD Construction Partners, Inc. | 13G/A | 7.3% | Dec 31, 2023 | 2y |
| BlackRock Inc. | BKF iShares, Inc. | 13G | 6.2% | Dec 31, 2023 | 2y |
| Mitchell P. Kopin | PTPI Petros Pharmaceuticals, Inc. | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| Hudson Bay Capital Management LP | PSQH PSQ Holdings, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Hudson Bay Capital Management LP | EMAT Evolution Metals & Technologies Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| VICTORY CAPITAL MANAGEMENT INC | COHU Cohu Inc | 13G/A | 6.26% | Dec 31, 2023 | 2y |
| Y.D. More Investments Ltd | DRIO DarioHealth Corp. | 13G/A | 4.73% | Dec 31, 2023 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 10.2% | Dec 31, 2023 | 2y |
| Mitchell P. Kopin | AGRX Agile Therapeutics, Inc | 13G/A | 0.9% | Dec 31, 2023 | 2y |
| Kirk Nielsen | CVRX CVRx, Inc. | 13G/A | 8.4% | Dec 31, 2023 | 2y |
| BlackRock Inc. | CRDO Credo Technology Group Holding Ltd | 13G/A | 7.7% | Dec 31, 2023 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 50% | Dec 31, 2023 | 2y |
| Apollo Management Holdings GP, LLC | IVCA Investcorp AI Acquisition Corp. Class A Ordinary Share | 13G/A | 0% | Dec 31, 2023 | 2y |
| Hudson Bay Capital Management LP | QOMO Qomolangma Acquisition Corp. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Timothy P. Horne | WTS Watts Water Technologies Inc | 13G/A | 17.9% | Dec 31, 2023 | 2y |
| BlackRock Inc. | BCLO BlackRock ETF Trust II | 13G/A | 10.9% | Dec 31, 2023 | 2y |
| HORIZON KINETICS ASSET MANAGEMENT LLC | ACGP Associated Capital Group, Inc. | 13G/A | 43.3% | Dec 31, 2023 | 2y |
| GSK plc | CVAC CureVac N.V. Ordinary Shares | 13G/A | 7.4% | Dec 31, 2023 | 2y |
| BlackRock Inc. | AOA iShares Core 80/20 Aggressive Allocation ETF | 13G/A | 8.7% | Dec 31, 2023 | 2y |